Relay Therapeutics, Inc.
RLAY· Nasdaq
RLAYRelay Therapeutics, Inc.
Filed Aug 27, 2020 · 10-Q · 58 days after period end · 0001193125-20-233120
| Metric | Q2 2020 | Q2 2019 |
|---|---|---|
| Net Income | -$26.72M | -$17.54M |
| EPS Diluted | -$6.06 | -$5.28 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Relay Therapeutics, Inc. · CIK 1812364 · Engraved from SEC EDGAR
ended Jun 30, 2020 · filed Aug 27, 2020 · 58 d after period end
